Janux Therapeutics
JANX· Manufacturing· Fiscal year ends in December
David Campbell, Ph.D. is the CEO of Janux Therapeutics and was paid $13.5M in FY2025 (Dec), up 50%.
Executives5
See all- 1David Campbell, Ph.D.President and Chief Executive OfficerFY2025
- 2Byron Robinson, Ph.D., J.D.Former Chief Strategy OfficerFY2025
- 3Janeen DoyleChief Corporate and Business Development OfficerFY2025
- 4Zachariah McIver, D.O., Ph.D.Former Chief Medical OfficerFY2025
- 5Thomas DiRaimondo, Ph.D.Chief Scientific OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allJanux Therapeutics paid its 5 named executives $32.2M in total in FY2025 (Dec). CEO David Campbell, Ph.D. was paid $13.5M of that.
| Name | |||
|---|---|---|---|
| David Campbell, Ph.D.President and Chief Executive Officer | |||
| Byron Robinson, Ph.D., J.D.Former Chief Strategy Officer | |||
| Janeen DoyleChief Corporate and Business Development Officer | Not disclosed | Not disclosed | |
| Zachariah McIver, D.O., Ph.D.Former Chief Medical Officer | Not disclosed | Not disclosed | |
| Thomas DiRaimondo, Ph.D.Chief Scientific Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2024 (Dec) proxy of Janux Therapeutics names 15 peer companies for pay. Among Janux Therapeutics and these peers, CEO pay was the highest of 1 and total shareholder return was the highest of 1.
1st highest of 1in Janux Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:
1st highest of 1in Janux Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Jay Lichter, Ph.D.Chair · 6 yr on the boardNot independent—Paid as an executive
- Alana McNultyDirector · 2 yr on the boardIndependentAudit—Paid as an executive
- Ron BarrettDirector · 2 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
- Sheila GujrathiDirector · 2 yr on the boardNot independent—Paid as an executive
- Winston KungDirector · 1 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Mar 8, 2024 | FY2023 |
